Nacuity Pharmaceuticals announced the closing of a $16.5 million Series B financing led by Foundation Fighting Blindness and its venture arm RD Fund. Additional existing investors also participated in the round.

The US Department of Defense (DoD) has awarded Weill Cornell Medicine a $1.27 million grant to develop a treatment for a rare but deadly eye disease that mostly affects military members who have suffered traumatic eye injuries in combat.

Schwind eye-tech-solutions has received funding for a new research project aimed at developing an ophthalmic laser system with ultra-short laser pulses[1], according to a company announcement.